Search Login Register
Fibrinolytic Agents
(Antithrombotic Agents)
Summary
Description:
Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN.
Also Known As:
Antithrombotic Agents; Antithrombic Drugs; Fibrinolytic Drugs; Thrombolytic Drugs; Thrombolytic Agents
Networked: 1939
relevant articles (184 outcomes,
265 trials/studies)
for this Bio-Agent
Key Diseases for which Fibrinolytic Agents is
Relevant
-
Myocardial Infarction
:
44 outcomes 81 studies in 475 results
-
Thrombosis (Thrombus)
:
35 outcomes 35 studies in 330 results
-
Stroke (Strokes)
:
29 outcomes 47 studies in 284 results
-
Hemorrhage
:
23 outcomes 25 studies in 271 results
-
Pulmonary Embolism
:
10 outcomes 7 studies in 88 results
Show All >>
Drugs Related to Fibrinolytic Agents
-
Heparin (Liquaemin)
-
Streptokinase
-
Tissue Plasminogen Activator (Alteplase)
-
Warfarin (Coumadin)
-
Aspirin (Acetylsalicylic Acid)
-
Fibrinolytic Agents (Antithrombotic Agents)
-
Urokinase-Type Plasminogen Activator (Urokinase)
-
glucuronyl glucosamine glycan sulfate (Vessel)
-
Plasminogen Activators (Plasminogen Activator)
-
Thrombin
Show All >>
Therapies Related to Fibrinolytic Agents
-
Catheters
-
Thrombolytic Therapy
-
Angioplasty (Angioplasty, Transluminal)
-
Microbubbles
-
Thoracostomy
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.